Multiple myeloma is characterized by a highly heterogeneous disease distribution within the bone marrow-containing skeletal system.

There is insufficient evidence on the efficacy of psychological interventions for lymphoma patients. This review aimed to present the research...

Multiple myeloma is a plasma cell neoplasm driven by primary (e.g. hyperdiploidy; IGH translocations) and secondary (e.g. 1q21 gains/amplifications...

Next generation sequencing (NGS) is a technology that broadens the horizon of knowledge of several somatic pathologies, especially in oncological and...

Eyelids may be affected in systemic, ocular adnexal and primary cutaneous lymphomas (PCLs). The frequency of eyelid involvement in PCLs is still not...

Prognostic value of circulating plasma cells detected by flow cytometry in newly diagnosed multiple myeloma patients: a systematic review and meta...

Cutaneous T-cell lymphoma (CTCL) involves a clonal expansion of malignant cells accumulating in the skin, a primary barrier site.

Conceptualizing an Integrative Multiple Myeloma Care: The Role of Nutrition, Supplements, and Complementary Modalities.

Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review.

Immunosequencing has emerged as a newer clinical test for assessment of T cell clonality in the blood and skin of cutaneous T-cell lymphoma (CTCL)...

Primary anaplastic-lymphoma-kinase (ALK)-positive large-cell lymphoma of the central nervous system (PCNS ALK-positive ALCL) is a rare entity, with a...

Multiple myeloma is the second most common malignant hematologic malignancy which evolved different strategies for immune escape from the host immune...